Jardiance Met 5 mg/500 mg
Jardiance Met 5 mg/500 mg is a medicine authorised by Swissmedic under authorisation number 65570. The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 12 November 2015 and the authorisation is valid without a time limit. ATC code A10BD20 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 65570 |
|---|---|
| Name | Jardiance Met 5 mg/500 mg |
| Full name | Jardiance Met 5 mg/500 mg, Filmtabletten |
| Authorisation holder | Boehringer Ingelheim (Schweiz) GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BD20 |
| First authorisation | 12 November 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Jardiance Met 5 mg/500 mg, Filmtabletten | B | 12 November 2015 |
| 2 | Jardiance Met 5 mg/850 mg, Filmtabletten | B | 12 November 2015 |
| 3 | Jardiance Met 5 mg/1000 mg, Filmtabletten | B | 12 November 2015 |
| 7 | Jardiance Met 12.5 mg/500 mg, Filmtabletten | B | 12 October 2017 |
| 8 | Jardiance Met 12.5 mg/850 mg, Filmtabletten | B | 12 October 2017 |
| 9 | Jardiance Met 12.5 mg/1000 mg, Filmtabletten | B | 12 October 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Tablette(n) | A10BD20 | 07.06.2. | B |
| 2 | 180 (2x90) | Tablette(n) | A10BD20 | 07.06.2. | B |
| 3 | 60 | Tablette(n) | A10BD20 | 07.06.2. | B |
| 4 | 180 (2x90) | Tablette(n) | A10BD20 | 07.06.2. | B |
| 5 | 60 | Tablette(n) | A10BD20 | 07.06.2. | B |
| 6 | 180 (2x90) | Tablette(n) | A10BD20 | 07.06.2. | B |
| 7 | 60 | Tablette(n) | A10BD20 | 07.06.2. | B |
| 8 | 180 (2x90) | Tablette(n) | A10BD20 | 07.06.2. | B |
| 9 | 60 | Tablette(n) | A10BD20 | 07.06.2. | B |
| 10 | 180 (2x90) | Tablette(n) | A10BD20 | 07.06.2. | B |
| 11 | 60 | Tablette(n) | A10BD20 | 07.06.2. | B |
| 12 | 180 (2x90) | Tablette(n) | A10BD20 | 07.06.2. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Jardiance Met 5 mg/500 mg authorised in Switzerland?
Yes. Jardiance Met 5 mg/500 mg is authorised by Swissmedic under authorisation number 65570, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Jardiance Met 5 mg/500 mg have?
Jardiance Met 5 mg/500 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Jardiance Met 5 mg/500 mg?
The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.